Skip to main content

Find Clinical Trials

Home
Conditions
Meningitis

Clinical trial condition

Meningitis

Explore clinical trials studying Meningitis. Study availability and eligibility vary by location and protocol.

118 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Meningitis trial results

Completed

Pharmacological Study of High Doses of Ceftriaxone in Meningitidis

NCT01745679

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Meningitis, +3 more
Locations: Tours universitary hospital Tours, France

Nantes Universitary Hospital Nantes, Loire Atlantique, France

Angers Universitary Hospital Angers, France

La Roche/Yon hospital La Roche/Yon, France

View Trial Details

Completed

Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

NCT01359449

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Pierrefonds, Quebec, Canada

View Trial Details

Completed

Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery

NCT02806284

Conditions: Meningitis, Nervous System Diseases, Neuroinflammatory Diseases
Locations: Not specified

View Trial Details

Completed

Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine

NCT00254995

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Oakland, California, United States

View Trial Details

Completed

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

NCT00862277

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: Little Rock, Arkansas, United States

Fountain Valley, California, United States

Marietta, Georgia, United States

Martinez, Georgia, United States

View all 20 locations

View Trial Details

Completed

Immunology and Safety of Menactra® in Children in Saudi Arabia

NCT00539032

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: AlKhaleej, Al-Qassim Region, Saudi Arabia

AlRabwa, Al-Qassim Region, Saudi Arabia

S. Buraida, Al-Qassim Region, Saudi Arabia

Safra-Al Midhnab, Al-Qassim Region, Saudi Arabia

View Trial Details

Completed

Dose Comparison Study of Menactra® in US Children

NCT00700635

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +8 more
Locations: Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

Boca Raton, Florida, United States

Viera, Florida, United States

View all 15 locations

View Trial Details

Completed

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

NCT00771849

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: London, United Kingdom

London, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®

NCT00850603

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: East Stroudsburg, Pennsylvania, United States

View Trial Details

Completed

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

NCT00269477

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Atlanta, Georgia, United States

Marietta, Georgia, United States

Woburn, Massachusetts, United States

Akron, Ohio, United States

View Trial Details